Shares of MediciNova, Inc. (NASDAQ:MNOV) have earned a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two investment analysts have rated the stock with a strong buy recommendation. Brokerages have set a twelve-month consensus price objective of $19.67 for the company and are […]
